Paragon Capital Management Inc. Makes New $1.31 Million Investment in Dolby Laboratories $DLB

Paragon Capital Management Inc. bought a new position in shares of Dolby Laboratories (NYSE:DLBFree Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 21,739 shares of the electronics maker’s stock, valued at approximately $1,306,000. Dolby Laboratories accounts for approximately 1.1% of Paragon Capital Management Inc.’s portfolio, making the stock its 24th largest holding.

A number of other large investors also recently bought and sold shares of the stock. Royal Bank of Canada increased its position in shares of Dolby Laboratories by 3.5% in the first quarter. Royal Bank of Canada now owns 68,367 shares of the electronics maker’s stock valued at $5,491,000 after buying an additional 2,298 shares in the last quarter. Goldman Sachs Group Inc. lifted its position in shares of Dolby Laboratories by 218.8% during the 1st quarter. Goldman Sachs Group Inc. now owns 249,574 shares of the electronics maker’s stock valued at $20,043,000 after buying an additional 171,288 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in shares of Dolby Laboratories by 5.6% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 238,216 shares of the electronics maker’s stock valued at $19,131,000 after buying an additional 12,598 shares in the last quarter. Focus Partners Wealth acquired a new stake in Dolby Laboratories in the 1st quarter valued at $390,000. Finally, EverSource Wealth Advisors LLC grew its stake in Dolby Laboratories by 273.3% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,598 shares of the electronics maker’s stock valued at $193,000 after acquiring an additional 1,902 shares during the period. 58.56% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on DLB shares. Wall Street Zen upgraded shares of Dolby Laboratories from a “hold” rating to a “buy” rating in a research report on Saturday, May 30th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Dolby Laboratories in a report on Friday, March 27th. Rosenblatt Securities reiterated a “buy” rating and set a $85.00 price objective on shares of Dolby Laboratories in a research note on Thursday, June 11th. Finally, Barrington Research reissued an “outperform” rating and set a $90.00 target price on shares of Dolby Laboratories in a report on Monday, June 15th. Three research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, Dolby Laboratories currently has a consensus rating of “Moderate Buy” and a consensus price target of $90.75.

View Our Latest Report on Dolby Laboratories

Dolby Laboratories Stock Up 0.1%

NYSE:DLB opened at $52.39 on Tuesday. Dolby Laboratories has a 52 week low of $50.73 and a 52 week high of $77.00. The stock’s fifty day moving average is $57.29 and its two-hundred day moving average is $61.55. The company has a market capitalization of $4.96 billion, a P/E ratio of 20.71 and a beta of 0.81.

Dolby Laboratories (NYSE:DLBGet Free Report) last announced its earnings results on Thursday, April 30th. The electronics maker reported $1.37 earnings per share for the quarter, topping the consensus estimate of $1.31 by $0.06. Dolby Laboratories had a net margin of 17.85% and a return on equity of 11.47%. The company had revenue of $395.63 million during the quarter, compared to analyst estimates of $385.80 million. During the same quarter last year, the firm posted $1.34 earnings per share. Dolby Laboratories’s revenue was up 7.0% compared to the same quarter last year. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. Sell-side analysts anticipate that Dolby Laboratories will post 3.21 earnings per share for the current fiscal year.

Dolby Laboratories Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, May 20th. Stockholders of record on Tuesday, May 12th were paid a $0.36 dividend. The ex-dividend date of this dividend was Tuesday, May 12th. This represents a $1.44 annualized dividend and a dividend yield of 2.7%. Dolby Laboratories’s dividend payout ratio (DPR) is presently 56.92%.

Insider Buying and Selling at Dolby Laboratories

In related news, SVP Shriram Revankar sold 3,000 shares of the company’s stock in a transaction that occurred on Friday, May 15th. The shares were sold at an average price of $54.90, for a total transaction of $164,700.00. Following the sale, the senior vice president directly owned 80,603 shares in the company, valued at approximately $4,425,104.70. This represents a 3.59% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP John D. Couling sold 7,666 shares of the stock in a transaction that occurred on Monday, June 1st. The shares were sold at an average price of $55.62, for a total transaction of $426,382.92. Following the completion of the sale, the senior vice president directly owned 118,727 shares in the company, valued at approximately $6,603,595.74. This represents a 6.07% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders have sold 39,791 shares of company stock worth $2,231,653. 37.93% of the stock is currently owned by company insiders.

Dolby Laboratories Company Profile

(Free Report)

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.

Featured Stories

Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories (NYSE:DLBFree Report).

Institutional Ownership by Quarter for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.